Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 2 min ago
Peer-reviewedCC BY-NC-NDTranslational cancer research

Efficacy and safety of antibody-drug conjugates in advanced small cell lung cancer: a systematic review and single-arm meta-analysis of prospective clinical trials

Related

  1. Efficacy and safety of antibody-drug conjugates in pretreated HER2-positive advanced breast cancer: a network meta-analysis of randomized controlled trials
    Fen Liu, Yong Pan, Jinlan Li +2
    Frontiers in pharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  2. Intracranial Activity of Deruxtecan-Based Antibody–Drug Conjugates in Non-Small Cell Lung Cancer Brain Metastases: A Systematic Review and Meta-Analysis of Prospective Trial Cohorts
    Tomasz Tykocki, Krzysztof Szalecki
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  3. Efficacy and safety of antibody–drug conjugates in EGFR-mutated non-small cell lung cancer after EGFR-TKI resistance: a systematic review and meta-analysis
    Yilin Chen, Shuaixuan Chen, Hang Zhang +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  4. Antibody–drug conjugates in advanced small-cell lung cancer: a systematic review and single-arm meta-analysis of later-line monotherapy
    Xinmiao Chen, Shaoxun Li, Huiying Li
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  5. Antibody–Drug Conjugates Plus Immune Checkpoint Inhibitors for Sustained Disease Control in Advanced Solid Tumors
    Meiling Xu, Jun Yin, Yao Li +1
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
BibTeX
@article{anon2026efficacy,
  title = {{Efficacy and safety of antibody-drug conjugates in advanced small cell lung cancer: a systematic review and single-arm meta-analysis of prospective clinical trials}},
  journal = {Translational cancer research},
  year = {2026},
  month = aug,
  url = {https://europepmc.org/article/PMC/PMC13657816},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Efficacy and safety of antibody-drug conjugates in advanced small cell lung cancer: a systematic review and single-arm meta-analysis of prospective clinical trials
PY  - 2026
DA  - 2026/08/28
JO  - Translational cancer research
UR  - https://europepmc.org/article/PMC/PMC13657816
SN  - 2218-676X
ER  -